Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;35(2):e14174.
doi: 10.1111/ctr.14174. Epub 2020 Dec 22.

Healthcare resource use among solid organ transplant recipients hospitalized with COVID-19

Madeleine R Heldman  1 , Olivia S Kates  1 , Brandy M Haydel  2 , Sander S Florman  2 , Meenakshi M Rana  3 , Zohra S Chaudhry  4 , Mayur S Ramesh  4 , Kassem Safa  5 , Camille N Kotton  6 , Emily A Blumberg  7 , Behdad D Besharatian  7 , Sajal D Tanna  8 , Michael G Ison  8   9 , Maricar Malinis  10 , Marwan M Azar  10 , Robert M Rakita  1 , Jose A Morillas  11 , Aneela Majeed  11 , Afrah S Sait  12 , Mario Spaggiari  13 , Vagish Hemmige  14 , Sapna A Mehta  15 , Henry Neumann  15 , Abbasali Badami  16 , Amy Jeng  16 , Jason D Goldman  1   17 , Anuradha Lala  18 , Marion Hemmersbach-Miller  19 , Margaret E McCort  14 , Valida Bajrovic  20 , Carlos Ortiz-Bautista  21 , Rachel Friedman-Moraco  22 , Sameep Sehgal  23 , Erika D Lease  24 , Ajit P Limaye  1 , Cynthia E Fisher  1
Affiliations

Healthcare resource use among solid organ transplant recipients hospitalized with COVID-19

Madeleine R Heldman et al. Clin Transplant. 2021 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

MRH reports receiving speaking fees from Cigna LifeSource, outside the submitted work. JDG reports contracted research from Gilead Sciences and grants from Viracor and Merck, outside the submitted work. VH reports being co‐investigator on a trial of leronlimab versus placebo for COVID and did not receive salary support for participation in this study; however, Montefiore Medical Center received payments for patients enrolled in the study. MGI reports advisory board fees from Shionogi, Celltrion, Genetech/Roche, Janssen, Viracor Eurofins, VirBio, and Allo Vir and research grants from Genetech/Roche, Janssen, Emergent BioSolutions, AiCuris, Hologic, and Shire, outside the submitted work. All other authors have no potential conflicts of interests to disclose relating to the present manuscript.

References

    1. Kates OS, Haydel BM, Florman SS, et al. COVID‐19 in solid organ transplant: a multi‐center cohort study. Clin Infect Dis. 2020. 10.1093/cid/ciaa1097 - DOI - PubMed
    1. Molnar MZ, Bhalla A, Azhar A, et al. Outcomes of critically ill solid organ transplant patients with COVID‐19 in the United States. Am J Transplant. 2020;20(11):3061‐3071. - PMC - PubMed
    1. Rinaldi M, Bartoletti M, Bussini L, et al. COVID‐19 in solid organ transplant recipients: No difference in survival compared to general population. Transplant Infect Dis. 2020;10.1111/tid.13421 - DOI - PMC - PubMed
    1. Coll E, Fernández‐Ruiz M, Sánchez‐Álvarez JE, et al. Covid‐19 in transplant recipients: the Spanish experience. Am J Transplant. 2020;10.1111/ajt.16369 - DOI - PMC - PubMed
    1. Hazard D, Kaier K, von Cube M, et al. Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID‐19 patients: a multistate approach. BMC Med Res Methodol. 2020;20(1):206. - PMC - PubMed

Publication types